| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 37 |
| 1 | ADALIMUMAB | 31 |
| 2 | ORAL SEMAGLUTIDE | 26 |
| 3 | INSULIN GLARGINE | 20 |
| 4 | METFORMIN | 19 |
| 5 | EVOLOCUMAB | 17 |
| 6 | METFORMIN ER 500 MG | 17 |
| 7 | METFORMIN ER 750 MG | 17 |
| 8 | INSULIN ASPART | 14 |
| 9 | PIMAVANSERIN TARTRATE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 1 | DINUTUXIMAB | 2 | 0.0023 |
| 2 | PSYLLIUM HUSK | 3 | 0.0022 |
| 3 | IMIPRAMINE HYDROCHLORIDE | 1 | 0.0018 |
| 4 | DOBUTAMINE HYDROCHLORIDE | 2 | 0.0015 |
| 5 | FECAL MICROBIOTA SPORES, LIVE-BRPK | 1 | 0.0008 |
| 6 | MOMELOTINIB | 1 | 0.0007 |
| 7 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 8 | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | 1 | 0.0005 |
| 9 | IDURSULFASE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 41 |
| 1 | Insulin Analog [EPC] | 39 |
| 2 | GLP-1 Receptor Agonist [EPC] | 33 |
| 3 | Corticosteroid [EPC] | 20 |
| 4 | PCSK9 Inhibitor [EPC] | 18 |
| 5 | Kinase Inhibitor [EPC] | 17 |
| 6 | Interleukin-23 Antagonist [EPC] | 16 |
| 7 | Benzodiazepine [EPC] | 15 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 9 | RANK Ligand Inhibitor [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 2 | PCSK9 Inhibitor [EPC] | 18 | 0.0007 |
| 3 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 5 | 0.0004 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 8 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |